{"nct_id":"NCT05303519","title":"Safusidenib Phase 2 Study in IDH1 Mutant Glioma","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-06-05","start_date_type":"ACTUAL","primary_completion_date":"2027-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2028-03-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NUVB"]}